HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nezamis, J. E. Articles by Stowe, D. F. Search for Related Content PubMed PubMed Citation Articles by Nezamis, J. E. Articles by Stowe, D. F.

1. The effect of prostaglandin E₁ (PGE₁) on gastric secretion was studied in dogs equipped with gastric fundic pouches, either innervated (Pavlov) or denervated (Heidenhain).

2. PGE₁ inhibited gastric secretion (volume, acid concentration, acid output, pepsin output) when given either by constant intravenous infusion or by single intravenous injection. The degree of inhibition was dose dependent.

3. The antisecretory effect of PGE₁ was demonstrated against gastric stimulants which operate through different mechanisms. Thus, PGE₁ counteracted the secretogogue effect of:

(a) histamine dihydrochloride; the ED₅₀ was 0·5-1·0 µg/kg. min for a submaximal dose, and 1·0-1·5 µg/kg. min for a maximal dose;

(b) pentagastrin; the ED₅₀ was around 0·25 µg/kg. min;

(c) food; the ED₅₀ was 0·5 to 0·75 µg/kg. min;

(d) 2-deoxyglucose; the ED₅₀ was less than 0·1 µg/kg. min.

4. Although in some experiments, nausea and vomiting were observed during administration of PGE₁, the antisecretory property of the substance is not related to a vomiting reflex, since

(a) an antiemetic, such as atropine, prevented vomiting without interfering with the effect of PGE₁, and

(b) profuse vomiting elicited by apomorphine did not reduce gastric secretion stimulated by either histamine or pentagastrin.

5. The mechanism by which PGE₁ inhibits gastric secretion is unknown. Studies by others have shown that the compound reduces gastric mucosal blood flow, inhibits acid formation from gastric mucosa when applied in vitro and may change the rate of formation of gastric cyclic AMP. It is likely that PGE₁ interferes with biochemical processes, within parietal and chief cells, which lead to elaboration of gastric juice.

6. Unlike most gastric inhibitors, PGE₁ appears to act as a protective shield against most, if not all, gastric stimulants. Since prostaglandins of the E series are naturally occurring substances and are normally present in the stomach, they may play a role in the regulation of gastric secretion.

This article has been cited by other articles:

				P. Li, T.-M. Chang, D. Coy, and W. Y. Chey Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE2 Am J Physiol Gastrointest Liver Physiol, January 1, 2000; 278(1): G121 - G127. [Abstract] [Full Text] [PDF]